0001785530-20-000001.txt : 20200813 0001785530-20-000001.hdr.sgml : 20200813 20200813142544 ACCESSION NUMBER: 0001785530-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 EFFECTIVENESS DATE: 20200813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc. CENTRAL INDEX KEY: 0001785530 IRS NUMBER: 823523180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-346661 FILM NUMBER: 201098743 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-952-0555 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 D/A 1 primary_doc.xml X0708 D/A LIVE 0001785530 Werewolf Therapeutics, Inc. 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA MASSACHUSETTS 02138 617-952-0555 DELAWARE None None Corporation true 2017 Daniel Hicklin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director David Cordo 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Luke Evnin 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Briggs Morrison 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Christoph Westphal 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Sakae Asanuma 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Alon Lazarus 1030 Massachusetts Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Pharmaceuticals Decline to Disclose 06b true 0001785530-19-000001 2019-08-02 false true false 0 56172597 56172597 0 false 10 0 0 0 false Werewolf Therapeutics, Inc. /s/ Daniel Hicklin Daniel Hicklin President and Chief Executive Officer 2020-08-13